|

Peritoneal Mesothelioma Prognosis: Searching for New Factors

peritoneal mesothelioma prognosisAn international research study including patients from 11 countries may help reveal new and better ways to predict peritoneal mesothelioma prognosis. 

Right now, doctors use three primary criteria to determine peritoneal mesothelioma prognosis. Those are how much cancer was in the abdomen at the time of surgery, how complete the surgery was, and the tumor grade. 

But about 70 percent of people treated for peritoneal cancers like mesothelioma have recurrent disease. The goal of the new study is to find more prognostic factors. Knowing these factors could help doctors make better choices about which patients are most likely to benefit from cytoreductive surgery (CRS). 

The CRS/HIPEC Procedure for Mesothelioma

Peritoneal mesothelioma occurs on the lining of the abdomen. Peritoneal mesothelioma prognosis is generally better than it is for pleural mesothelioma. Advances in cytoreductive surgery (CRS) is a big reason for that. 

During cytoreduction, surgeons try to remove all the malignant tissue they can see. This is often followed by heated intraperitoneal chemotherapy (HIPEC). HIPEC involves rinsing the abdomen with a warm solution of cancer-killing chemicals. This happens immediately after CRS as a way to kill any remaining mesothelioma cells. 

Mesothelioma patients who have CRS/HIPEC usually live longer than those who do not. CRS/HIPEC has improved peritoneal mesothelioma prognosis. But the cancer still recurs for most people. 

One problem is that right now peritoneal mesothelioma prognosis is based on factors that doctors can only know after surgery. The international research team hopes to identify more presurgical prognostic factors for people with peritoneal cancers. They hope this will lead to more informed treatment decisions and better outcomes. 

The Future of Peritoneal Mesothelioma Prognosis

The new international study will include a variety of people with peritoneal (abdominal lining) cancers who are having CRS. 

Their peritoneal cancer may have started in another place in the body, such as the colon, appendix, or ovaries. Or it could have originated on the peritoneal lining like peritoneal mesothelioma.

Researchers will analyze patient demographics as well as their clinical information. They will look at their imaging studies, the details of their surgeries, and their lymph node involvement. They will also assess the pathology of their tumors. 

The answers could have a big impact on how doctors determine peritoneal mesothelioma prognosis in the future.

“A correlation between the surgical, radiological and pathological findings will be performed and the impact of these potential prognostic factors on progression-free and overall survival determined,” states the report.

The large-scale peritoneal surgery study includes research centers in India, France, Italy, the US, The Netherlands, and others. Peritoneal mesothelioma is the rarest of the cancers they plan to study. An estimated 500 Americans receive a peritoneal mesothelioma diagnosis each year. 

Source:

Bhatt, A, et al, “Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumours treated by cytoreductive surgery: study protocol of a prospective, multicentre, observational study”, July 5, 2021, BMJ Open, https://bmjopen.bmj.com/content/11/7/e046819

 

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…

  • | |

    Spanish Mesothelioma Deaths Likely to Continue for Decades

    New research in Spain suggests that mesothelioma deaths will continue in the country until the “last surviving member” of the group of people exposed to occupational asbestos succumbs to the disease. Like many countries, Spain used asbestos heavily in the first half of the 20th century, especially in construction, where the mineral was prized for its durability, low cost, and resistance to fire and corrosion.  Asbestos was banned in Spain in 2002. Observing that more than 2.5 million metric tons of asbestos were imported into Spain from 1906 to 2002, researchers say deaths from mesothelioma have risen steadily. Between 1976 and 1980, a total of 491 Spanish people died of mesothelioma. By the 5-year period from 2006 to 2010, that…

  • | |

    Repeat HIPEC Improves Mesothelioma Survival

    If one cytoreductive surgery and HIPEC procedure for mesothelioma is good, subsequent treatments may be even better. That is the central message of research conducted at the Moffitt Cancer Center in Florida. The study’s aim was to assess overall survival among peritoneal mesothelioma patients who had not just one, but two or more rounds of heated intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery. The cytoreduction/HIPEC approach has become popular for peritoneal mesothelioma, a treatment-resistant cancer of abdominal membranes caused by asbestos. Cytoreductive surgery involves removing as much of the mesothelioma tumor as possible from the abdomen. Because the shape and spreading pattern of mesothelioma tumors make complete cytoreduction difficult, the surgery is often followed by a rinse with a heated solution…